alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C.  20549

                                   FORM 15

     CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
     12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
     FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934.
                                                      000-08512
                                                ----------------------
                                                Commission File Number

                            MONARCH SERVICES, INC.
         --------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


          4517 Harford Road, Baltimore, Maryland 21214    410-254-9200
         ---------------------------------------------------------------
          (Address, including zip code, and telephone number, including
            area code, of registrant's principal executive offices)

                     Common Stock, par value $0.25 per share
         --------------------------------------------------------------
           (Titles of each class of securities covered by this Form)

                                    N/A
         --------------------------------------------------------------
           (Titles of all other classes of securities for which a duty
              to file reports under section 13(a) or 15(d) remains)

          Please place an X in the box(es) to designate the appropriate
     rule provision(s) relied upon to terminate or suspend the duty to
     file reports:

               Rule 12g-4(a)(1)     [ ]
               Rule 12g-4(a)(2)     [x]
               Rule 12h-3(b)(1)(i)  [ ]
               Rule 12h-3(b)(1)(ii) [ ]
               Rule 15d-6           [ ]

          Approximate number of holders of record as of the certification
               or Notice date:   484
                               -------

          Pursuant to the requirements of the Securities Exchange Act of
     1934 Monarch Services, Inc. has caused this certification/notice to
     be signed on its behalf by the undersigned duly authorized person.

     Date:  March 30, 2010          By:  Jackson Y. Dott
                                         ---------------
                                         Jackson y. Dott
                                         President & CEO

     Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of
     the General Rules and Regulations under the Securities Exchange Act
     of 1934.  The registrant shall file with the Commission three copies
     of Form 15, one of which shall be manually signed.  It may be signed
     by an officer of the registrant, by counsel or by any other duly
     authorized person.  The name and title of the person signing the form
     shall be typed or printed under the signature.
JEFF L. ROSE, CHIEF JUSTICE DAVID PURYEAR, JUSTICE BOB PEMBERTON, JUSTICE MELISSA GOODWIN, JUSTICE SCOTT K. FIELD, JUSTICE CINDY OLSON BOURLAND, JUSTICE

The Honorable Velva L. Price Civil District Clerk 

### Travis County Courthouse P. O. Box 1748 Austin, TX 78767 * DELIVERED VIA E-MAIL * 

# Court ofAppeals Third District ofTexas P.O. BOX 12547, AUSTIN, TEXAS 78711-2547 www.txcourls.gov/3rclcoa.aspx (512) 463-1733



### 12- Marcir5T2015 JEFFREY D. KYLE, CLERK



### RE: Court ofAppeals Number: 03-09-00313-CV Trial Court Case Number: D-1 -GN-08-000511 

### Style: John A. Bollier and Leslie J. Bollier v. Austin Gurdwara Sahib, Inc. d/b/a Gurdwara Sahib Austin
Dear Honorable Velva L. Price: 

### The Third Court ofAppeals has issued the mandate in this cause. Therefore, I am returning the following original exhibits: 

### Reporter's Record Volume 5 and Supplemental Reporter's Record Volume 1.

Very truly yours,
Jeffrey D. Kyle, Clerk 

## FiledinThe DistrictCourt

of Travis County, Texas



## MAR \ I 2015 At M.

# <wf VelvaL. Price, DistrictClerk
EXHIBIT 32
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(B) OF THE
SECURITIES EXCHANGE ACT, AS AMENDED
    1.
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and2.
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
 /s/ Robert B. WiseRobert B. WiseChief Executive Officer/s/ Clyde A. McArthurClyde A. McArthurChief Financial OfficerDate:  December 29, 2008
EX-32.2  906 CERTIFICATION

Exhibit 32.2

 

 

Credex Corporation

Certification Pursuant to 18 U.S.C. § 1350

Section 906 Certifications

 

Pursuant to 18 U.S.C. §1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002 (Public Law 107-204), theundersigned, Arunkumar Rajapandy, the Chief Financial Officer of Credex Corporation, a Delaware corporation (the "Company"),hereby certify that:

 

1.     The Company'sQuarterly Report on Form 10-Q for the period ended March 31, 2012, as filed with the U.S. Securities and Exchange Commission onthe date hereof (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities ExchangeAct of 1934; and

 

2.     The informationcontained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

This Certification is signed on May 14, 2012.

 

Credex Corporation

 

By: __/S/ Arunkumar Rajapandy_

Arunkumar Rajapandy,

Chief Financial Officer

 

 

A signed original of this written statement required by Section906 has been provided to Credex Corporation and will be retained by Credex Corporation and furnished to the Securities andExchange Commission or its staff upon request.
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 10-Q/A-1

[X]
     QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934FOR THE QUARTERLY PERIOD ENDED April 30, 2008OR[   ]
     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934


Commission file number333-150192DONG FANG MINERALS, INC.(Exact name of registrant as specified in its charter)NEVADA(State or other jurisdiction of incorporation or organization)#1006, Bldg. A, Yang Guang 100 International Apartment #2Guanghua RoadChaoyang District, Beijing, P.R. China(Address of principal executive offices, including zip code.)(86) 010-5100-1006(telephone number, including area code)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.YES [X]    NO [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer, non-accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer
     [   ]
     Accelerated filer
     [   ]Non-accelerated filer
     [   ]
     Smaller reporting company
     [X]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).YES [X]    NO [   ]

State the number of shares outstanding of each of the issuers classes of common equity, as of the latest practicable date: 5,000,000 as of June 19, 2008

---

ITEM 6.      EXHIBITS.

The following documents are included herein:

Exhibit No.
     Document Description31.1
     Certification of Principal Executive Officer and Principal Financial Officer pursuant toSection 302 of the Sarbanes-Oxley Act of 2002.32.1
     Certification of Chief Executive Officer and Chief Financial Officer pursuant to section906 of the Sarbanes-Oxley Act of 2002.








SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following person on behalf of the Registrant and in the capacities on this 17thday of November, 2008.

DONG FANG MINERALS, INC.(Registrant)BY:
     JIAN HONG LIUJian Hong LiuPresident, Principal Executive Officer, PrincipalFinancial Officer, Principal Accounting Officer andTreasurer.






-2-

---

EXHIBIT INDEX

Exhibit No.
     Document Description31.1
     Certification of Principal Executive Officer and Principal Financial Officer pursuant toSection 302 of the Sarbanes-Oxley Act of 2002.32.1
     Certification of Chief Executive Officer and Chief Financial Officer pursuant to section906 of the Sarbanes-Oxley Act of 2002.






















-3-

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Microbiology, Infectious Diseases and AIDS Initial Review Group; Acquired Immunodeficiency Syndrome Research Review Committee, AIDS Research Review Committee March 2008 Meeting.                    

*Date:*                         March 25, 2008.                    

*Time:*                         9 a.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).2 17 CFR 240.19b-4.                     

*Contact Person:*                         Erica L. Brown, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2639,                         *ebrown@niaid.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: February 19, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-838  Filed 2-25-08; 8:45 am]

BILLING CODE 4140-01-M
I 

115TH CONGRESS 

2D SESSION H. R. 5964 

To amend the Professional Boxing Safety Act of 1996 to provide additional 

safety standards for professional boxing. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 24, 2018 

Mr. CARTWRIGHT (for himself and Ms. EDDIE BERNICE JOHNSON of Texas) 

introduced the following bill; which was referred to the Committee on 

Education and the Workforce, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

A BILL 

To amend the Professional Boxing Safety Act of 1996 to 

provide additional safety standards for professional boxing. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Professional Boxing 

5 Safety Enhancement Act of 2018’’. 

6 SEC. 2. ADDITIONAL SAFETY STANDARDS. 

7 Section 5 of the Professional Boxing Safety Act of 

8 1996 (15 U.S.C. 6304) is amended— 


sradovich on DSK3GMQ082PROD with BILLS
2 

•HR 5964 IH

1 (1) in the matter preceding paragraph (1), by 

2 striking ‘‘or an alternative requirement in effect 

3 under regulations of a boxing commission that pro4 vides equivalent protection of the health and safety 

5 of boxers’’; 

6 (2) by redesignating paragraphs (3) and (4) as 

7 paragraphs (5) and (6), respectively; and 

8 (3) by striking paragraph (2) and inserting the 

9 following: 

10 ‘‘(2) A boxer must provide with the application 

11 for a license or for renewal of the license an original 

12 or certified copy of the results of medical tests 

13 which— 

14 ‘‘(A) were performed by a laboratory dur15 ing the calendar year for which the license is 

16 being issued or no earlier than 30 days before 

17 the date on which the application is submitted; 

18 ‘‘(B) show that the boxer is not infected 

19 with the human immunodeficiency virus; and 

20 ‘‘(C) show that the boxer is not infected 

21 with the hepatitis virus. 

22 ‘‘(3) An ambulance continuously present on 

23 site. 


sradovich on DSK3GMQ082PROD with BILLS
3 

•HR 5964 IH

1 ‘‘(4) Emergency medical personnel with appro2 priate resuscitation equipment continuously present 

3 on site.’’. 

Æ 


sradovich on DSK3GMQ082PROD with BILLS
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

KEITH WILLIAMS
, Appellant,

v.

PENELOPE WILLIAMS
, Appellee

.

No. 4D 19

- 403

[ November 27, 2019 ]

Appeal from the Circuit Court for the Fifteenth Judicial Circuit, Palm Beach County ; Janis Brustares Keyser , Judge; L.T. Case No.

502014DR003451 XXXXMB

.

Abigail Beebe of The Law Office of Abigail Beebe, P.A., West Palm Beach, for appellant.

Daniel J. Kole o s of Kole o s Rosenberg McMahon P.L., Fort Lauderdale, for appellee.

P ER C URIAM

.

Af firmed.

W ARNER
, T AYLOR and C ONNER

, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. 

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel, Oxygen Resuscitation of Low Birth Weight Infants.                    

*Date:*                         March 20, 2008.                    

*Time:*                         2 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Rita Anand, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 496-1487,                         *anandr@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.939, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: February 20, 2008.

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-855 Filed 2-26-08; 8:45 am]

BILLING CODE 4140-01-M
REPORT OF INDEPENDENT
AUDITORS


The Board of Directors
Nuveen Exchange-Traded Funds

In planning and performing our audit of the financial statements
of each of the Nuveen Exchange-Traded Funds listed in Exhibit
A attached hereto (the "Funds") for the year ended July 31,
2000, we considered its internal control, including control
activities for safeguarding securities, to determine our auditing
procedures for the purpose of expressing our opinion on the
financial statements and to comply with the requirements of
Form N-SAR, and not to provide assurance on internal control.

The management of the Funds is responsible for establishing
and maintaining internal control.  In fulfilling this responsibility,
estimates and judgments by management are required to assess
the expected benefits and related costs of internal control.
Generally, internal controls that are relevant to an audit pertain
to the entity's objective of preparing financial statements for
external purposes that are fairly presented in conformity with
generally accepted accounting principles.  Those internal
controls include the safeguarding of assets against unauthorized
acquisition, use, or disposition.


Because of inherent limitations in any internal control,
misstatements due to errors or fraud may occur and not be
detected.  Also, projections of any evaluation of internal control
to future periods are subject to the risk that internal control may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.

Our consideration of internal control would not necessarily
disclose all matters in internal control that might be material
weaknesses under standards established by the American
Institute of Certified Public Accountants. A material weakness is
a condition in which the design or operation of one or more of
the specific internal control components does not reduce to a
relatively low level the risk that errors or fraud in amounts that
would be material in relation to the financial statements being
audited may occur and not be detected within a timely period by
employees in the normal course of performing their assigned
functions.  However, we noted no matters involving internal
control, including control activities for safeguarding securities,
and its operation that we consider to be material weaknesses as
defined above as of July 31, 2000.

This report is intended solely for the information and use of the
Board of Directors and management of the Nuveen Exchange-
Traded Funds and the Securities and Exchange Commission and
is not intended to be and should not be used by anyone other
than these specified parties.



     ERNST & YOUNG LLP
/s/ ERNST & YOUNG LLP


Chicago, Illinois
September 8, 2000

Exhibit A


Nuveen Arizona Premium Income Municipal Fund, Inc.
Nuveen Michigan Quality Income Municipal Fund, Inc.
Nuveen Michigan Premium Income Municipal Fund, Inc.
Nuveen Ohio Quality Income Municipal Fund, Inc.
Nuveen Texas Quality Income Municipal Fund, Inc.
Exhibit
32.1




CERTIFICATION
PURSUANT TO 18 U.S.C. 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the quarterly report of First China Pharmaceutical Group, Inc.
(the “Company”) on Form 10-Q for the quarterly period ended September 30, 2010,
as filed with the Securities and Exchange Commission on the date hereof (the
“Report”), I, Zhen Jiang Wang, Chief Executive Officer of the Company, certify,
to the best of my knowledge and belief, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:





i.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d));
      and




ii.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.




Date:  November
17, 2010





/s/ Zhen Jiang WangName:
      Zhen Jiang WangTitle:
      Chief Executive Officer (Principal Executive
  Officer)
[Federal Register Volume 73, Number 32 (Friday, February 15, 2008)]
[Notices]
[Page 8888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-693]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Child Health and Human Development Special Emphasis Panel, 
February 20, 2008, 2 p.m. to February 20, 2008, 3 p.m., National 
Institutes of Health, 6100 Executive Boulevard, 5B01, Rockville, MD 
20852 which was published in the Federal Register on January 28, 2008, 
73 FR 4883-4884.
    The meeting will be on February 21, 2008, 10 a.m. The meeting is 
closed to the public.

    Dated: February 8, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-693 Filed 2-14-08; 8:45 am]
BILLING CODE 4140-01-M